Reaction

Vulvovaginal Swelling reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,795 reports · 16 co-occurring drugs

As of the last recalculation, Vulvovaginal Swelling appears in 1,795 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 511.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Miconazole Nitrate317511.3530.6
Etonogestrel And Ethinyl Estradiol5026.926.9
Conjugated Estrogens6212.712.8
Estradiol9012.712.7
Estrogens, Conjugated6212.512.5
Estradiol Gel 0.1%4311.311.3
Estradiol Transdermal4311.311.3
Diphenhydramine Hcl99.49.4
Drs. Clotrimazole99.19.1
Family Wellness Clotrimazole99.19.1
Clotrimazole Topical99.19.1
Dorzolamide Hydrochloride And Timolol Maleate68.88.8
Empagliflozin305.25.2
Copper195.25.2
Levonorgestrel764.54.5
Etonogestrel92.22.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.